We serve Chemical Name:5-methoxy-3-oxido-2,1,3-benzoxadiazol-3-ium CAS:3524-06-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-methoxy-3-oxido-2,1,3-benzoxadiazol-3-ium
CAS.NO:3524-06-9
Synonyms:6-methoxybenzo[c]1,2,5-oxadiazol-1-ol;5-methoxy-benzofurazan N-oxide;5-methoxybenzofuroxan;5-methoxy-benzo[1,2,5]oxadiazole 3-oxide;5-methoxybenzo[c][1,2,]oxadiazol-1-oxide;5-METHOXYBENZOFURAZAN-3-OXIDE;5-methoxybenzofurazan oxide;6-Methoxy-2,1,3-benzoxadiazole 1-oxide;MFCD00192265;5-methoxybenzofuroxane;6-Methoxybenzofuroxan
Molecular Formula:C7H6N2O3
Molecular Weight:166.13400
HS Code:2934999090
Physical and Chemical Properties:
Melting point:115-117ºC(lit.)
Boiling point:291.2ºC at 760 mmHg
Density:1.46g/cm3
Index of Refraction:1.628
PSA:60.72000
Exact Mass:166.03800
LogP:1.26490
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-methoxybenzo[c]1,2,5-oxadiazol-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Methoxybenzofuroxan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-methoxybenzofuroxan Use and application,5-methoxy-benzofurazan N-oxide technical grade,usp/ep/jp grade.
Related News: This includes chemical APIs. 5-methoxy-3-oxido-2,1,3-benzoxadiazol-3-ium manufacturer High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies. 5-methoxy-3-oxido-2,1,3-benzoxadiazol-3-ium supplier On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday. 5-methoxy-3-oxido-2,1,3-benzoxadiazol-3-ium vendor The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 5-methoxy-3-oxido-2,1,3-benzoxadiazol-3-ium factory High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.
